Asklepios BioPharma Launches New Biotech Actus Therapeutics Post author:Sam Post published:December 14, 2017 Post category:BioPharma Asklepios BioPharma is forming a new biotech portfolio company, Actus Therapeutics. Source: BioSpace You Might Also Like This CRISPR Startup Co-Founded by a 30-Year-Old Just Nabbed $38 Million for Pig-to-Human Transplants March 15, 2017 Astellas and Universal Cells Ink $124M R&D Pact for Undisclosed Indication October 19, 2017 NIH Hooks Up With 11 Top Biopharmas for $215 Million Cancer Moonshot Deal October 12, 2017
This CRISPR Startup Co-Founded by a 30-Year-Old Just Nabbed $38 Million for Pig-to-Human Transplants March 15, 2017
